MicroPort CardioFlow Medtech Inkomsten in het verleden
Verleden criteriumcontroles 0/6
MicroPort CardioFlow Medtech's earnings have been declining at an average annual rate of -15.7%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 27.3% per year.
Belangrijke informatie
-15.7%
Groei van de winst
-8.3%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | 27.3% |
| Rendement op eigen vermogen | -15.9% |
| Nettomarge | -91.0% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe MicroPort CardioFlow Medtech geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 383 | -349 | 297 | 211 |
| 31 Mar 24 | 360 | -410 | 295 | 224 |
| 31 Dec 23 | 336 | -472 | 293 | 237 |
| 30 Sep 23 | 319 | -491 | 273 | 246 |
| 30 Jun 23 | 303 | -511 | 253 | 254 |
| 31 Mar 23 | 277 | -483 | 243 | 239 |
| 31 Dec 22 | 251 | -454 | 233 | 224 |
| 30 Sep 22 | 245 | -345 | 213 | 203 |
| 30 Jun 22 | 239 | -236 | 193 | 182 |
| 31 Mar 22 | 220 | -209 | 173 | 166 |
| 31 Dec 21 | 201 | -183 | 152 | 151 |
| 30 Sep 21 | 176 | -265 | 131 | 133 |
| 30 Jun 21 | 151 | -346 | 111 | 116 |
| 31 Mar 21 | 128 | -372 | 104 | 106 |
| 31 Dec 20 | 104 | -398 | 97 | 97 |
| 31 Dec 19 | 22 | -145 | 37 | 97 |
Kwaliteitswinsten: MROP.F is currently unprofitable.
Groeiende winstmarge: MROP.F is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: MROP.F is unprofitable, and losses have increased over the past 5 years at a rate of 15.7% per year.
Versnelling van de groei: Unable to compare MROP.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: MROP.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Rendement op eigen vermogen
Hoge ROE: MROP.F has a negative Return on Equity (-15.92%), as it is currently unprofitable.